Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics

Y Han, SY Kim - Experimental & Molecular Medicine, 2023 - nature.com
Senescence compromises the essential role that the endothelium plays in maintaining
vascular homeostasis, so promoting endothelial dysfunction and the development of age …

Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem

K Evangelou, PVS Vasileiou… - Physiological …, 2023 - journals.physiology.org
Cardiovascular diseases (CVDs) constitute the prime cause of global mortality, with an
immense impact on patient quality of life and disability. Clinical evidence has revealed a …

Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to TTN mutations

A Fomin, A Gärtner, L Cyganek, M Tiburcy… - Science translational …, 2021 - science.org
Heterozygous truncating variants in TTN (TTNtv), the gene coding for titin, cause dilated
cardiomyopathy (DCM), but the underlying pathomechanisms are unclear and disease …

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X Xiao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

The regulatory roles of p53 in cardiovascular health and disease

H Men, H Cai, Q Cheng, W Zhou, X Wang… - Cellular and Molecular …, 2021 - Springer
Cardiovascular disease (CVD) remains the leading cause of mortality globally, so further
investigation is required to identify its underlying mechanisms and potential targets for its …

Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease

FG Tahrir, D Langford, S Amini… - Journal of cellular …, 2019 - Wiley Online Library
Mitochondria play an important role in maintaining cardiac homeostasis by supplying the
major energy required for cardiac excitation–contraction coupling as well as controlling the …

[HTML][HTML] Cellular senescence in cardiac diseases

I Shimizu, T Minamino - Journal of cardiology, 2019 - Elsevier
Replicative capacity of somatic cells is limited. It indicates that aging also develops at the
cellular level, and this is described as “cellular senescence”. Senescent cells become …

Cardiac metabolism in HFpEF: from fuel to signalling

F Capone, C Sotomayor-Flores, D Bode… - Cardiovascular …, 2022 - academic.oup.com
Heart failure (HF) is marked by distinctive changes in myocardial uptake and utilization of
energy substrates. Among the different types of HF, HF with preserved ejection fraction …

Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology

L Carrier, G Mearini, K Stathopoulou, F Cuello - Gene, 2015 - Elsevier
More than 350 individual MYPBC3 mutations have been identified in patients with inherited
hypertrophic cardiomyopathy (HCM), thus representing 40–50% of all HCM mutations …

Metabolic origins of heart failure

AR Wende, MK Brahma, GR McGinnis… - Basic to Translational …, 2017 - jacc.org
For more than half a century, metabolic perturbations have been explored in the failing
myocardium, highlighting a reversion to a more fetal-like metabolic profile (characterized by …